ML298, formerly known as CID53393915, is a potent, specific inhibitor of Phospholipase D2 (PLD2; IC50 = 355 nM). ML298 does not affect PLD1 activity at concentrations up to 20 μM. References: O'Reilly MC, Scott SA, Daniels JS, Morrison R, Engers JL, Oguin T, Thomas P, Brown HA, Lindsley CW. A Next generation PLD2 inhibitor with improved physiochemical properties and DMPK profile for translational in vivo. 2014 Apr 15 [updated 2015 Jan 16]. Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-. Available from .gov/books/NBK280050/ PubMed PMID: 25834904.

纯度：≥98%

CAS：1426916-02-0